2020 HMS I-Hub and HMS Translator Symposium

November 2020 Update:

Thank you for your interest in the 2020 HMS I-Hub and HMS Translator Symposium.
This event has passed and a recording can be viewed here:
 

...

Please mark your calendars for a special event and join us on Wednesday, October 28, from 1:00pm to 3:30pm ET via Zoom Webinar to celebrate the launch of the HMS Ideation Hub (I-Hub) and HMS Translator. The symposium will feature a special discussion about emerging techniques, the future of medicine, and the direction of the industry as well as presentations by (in order of appearance):

George Q. Daley, MD, PhD
Dean of the Faculty of Medicine, Harvard University
Caroline Shields Walker Professor of Medicine, Harvard Medical School
 
Tim Mitchison, PhD
Director of the I-Hub, Harvard Medical School
Hasib Sabbagh Professor of Systems Biology, Harvard Medical School
 
Ifat Rubin-Bejerano, PhD
Director of Translational Research Programs, Harvard Medical School
 
Mark Namchuk, PhD
Executive Director of Therapeutics Translation, Harvard Medical School
 
Len Blavatnik, MBA ’89
Founder and Chairman, Access Industries
 

The "Frontiers in Therapeutics" panel discussion will be moderated by Mark Namchuk and feature the following panelists:

Linda Avey
Co-Founder and Chief Executive Officer, Precisely, Inc.
 
Kevin Bitterman, PhD
Partner, Atlas Venture
 
Jose-Carlos Gutiérrez-Ramos, PhD
Vice President, Global Drug Discovery, AbbVie
 
Timothy A. Springer, PhD
Latham Family Professor of Medicine, Professor Pediatrics
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
Program in Cellular and Molecular Medicine, Boston Children's Hospital
Co-Founder and Executive Chair, Institute for Protein Innovation
 
 

The I-Hub (Ideation Hub) at Harvard Medical School is a new initiative that aims to build community and catalyze ideation in therapeutics science, help faculty and students assemble interdisciplinary teams to prosecute translational projects, and provide early-stage support.

The Translator at Harvard Medical School is a new organization that is tasked with accelerating the movement of fundamental science at Harvard Medical School toward the medicines of tomorrow. The Translator works across a number of disease areas and therapeutic modalities via several translational research programs.

...

Agenda

1:00pm
Opening Remarks
 
George Q. Daley, PhD
Dean of the Faculty of Medicine, Harvard University
Caroline Shields Walker Professor of Medicine, Harvard Medical School
1:10pm
Presentation of I-Hub
 
Tim Mitchison, PhD
Director of the I-Hub, Harvard Medical School
Hasib Sabbagh Professor of Systems Biology, Harvard Medical School
1:25pm
Presentation of Q-FASTR
 
Ifat Rubin-Bejerano, PhD
Director of Translational Research Programs, Harvard Medical School
1:35pm
Presentation of Translator
 
Mark Namchuk, PhD
Executive Director of Therapeutics Translation, Harvard Medical School
2:00pm 
BREAK
2:10pm
Therapeutics Graduate Program Student Lightning Talks
2:40pm
Frontiers in Therapeutics Panel Discussion
 
Mark Namchuk, PhD
Executive Director of Therapeutics Translation, Harvard Medical School
Linda Avey
Co-Founder and Chief Executive Officer, Precisely, Inc.
Kevin Bitterman, PhD
Partner, Atlas Venture
Jose-Carlos Gutiérrez-Ramos, PhD
Vice President, Global Drug Discovery, AbbVie
Timothy A. Springer, PhD
Latham Family Professor of Medicine, Professor Pediatrics
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
Program in Cellular and Molecular Medicine, Boston Children's Hospital
Co-Founder and Executive Chair, Institute for Protein Innovation
3:20pm
Closing Remarks
 
Len Blavatnik, MBA ’89
Founder and Chairman, Access Industries